---
category: news
title: "Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC"
excerpt: "OnKai's AI models redefine the methodologies and economics of clinical trials. TEL AVIV, Israel, July 10, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (\"Galmed\""
publishedDateTime: 2023-07-10T13:44:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
webUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
type: article
quality: 14
heat: 14
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "xZZYKYtDQ0Vk2/pPIaedx5/T4b9EbovvB6U8/4e5RQOKEY2JCpqKUKb2mCQUbo2Z0gsb/qpbnULMq2bd5z2OqhK5PVz+RliVGHHjsjoWeTYHqgtGAAnXeTFa0PX1nllsx9C9kbKDLMOLHPXQ9rlnqtvqdiHdyapaTjixDP5WDlI58w4yOM/rowEGtD8S49DgQKSOhvKEhAXZ+x22AjOolsDCfzo8oVYdE92THhxTDtowfajGk+8Ca53Scuza/4oTpCA5q4T/oQbHLHnukMLjvyp55UzUzW84qSvN3p49YlNtO3ftqbhFBOa3nxZS53bBbeOCWVGx0IkYm9JeiCy8Jrw+P964//75f6dpaonx/XA=;HxhVdejmTwAxnU3sgXCMpQ=="
---

